Health Canada approves MSD’s Keytruda for NSCLC stages

Health Canada has approved MSD's Keytruda for treating adults with resectable stage II, IIIA or IIIB NSCLC.

Feb 13, 2025 - 06:00

Health Canada approves MSD’s Keytruda for NSCLC stages

Health Canada has approved MSD's Keytruda for treating adults with resectable stage II, IIIA or IIIB NSCLC.

Read the original article

Tags:

Previous Article

EC grants marketing authorisation to BridgeBio’s ATTR-CM treatment

Be realistic, responsive and transparent: how to engage underperforming sites

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

Coherus allies with Mark Cuban to challenge AbbVie for Humira biosimilar

Coherus allies with Mark Cuban to challenge AbbVie for ...

Jun 3, 2023

Anavex’s slow journey to failure

Anavex’s slow journey to failure

Jan 4, 2024

Ultra-processed food is causing a boom for obesity drug Ozempic

Ultra-processed food is causing a boom for obesity drug...

Nov 9, 2024